2010 (ChemInform Abstract A PalladiumCopper Bimetallic Catalytic System)
2010 (ChemInform Abstract A PalladiumCopper Bimetallic Catalytic System)
2010 (ChemInform Abstract A PalladiumCopper Bimetallic Catalytic System)
net/publication/46160173
CITATIONS READS
90 153
7 authors, including:
Bo Liu Xiyu Li
Sun Yat-Sen University of Medical Sciences Sichuan University
128 PUBLICATIONS 3,934 CITATIONS 25 PUBLICATIONS 452 CITATIONS
Qiang Guo
Dell
20 PUBLICATIONS 962 CITATIONS
SEE PROFILE
Some of the authors of this publication are also working on these related projects:
All content following this page was uploaded by Xiyu Li on 28 August 2018.
Bo Liu, Xurong Qin, Kaizhi Li, Xiyu Li, Qiang Guo, Jingbo Lan, and Jingsong You*[a]
The Suzuki–Miyaura coupling ranks as one of the most arylation of azoles with arylboronic acid hitherto. In this
powerful and reliable biaryl forming reactions.[1] Traditional- context, we wish to develop an efficient general methodolo-
ly, these transition-metal catalyzed cross-couplings require gy to achieve the direct Suzuki–Miyaura-type coupling of a
aryl halides or pseudohalides to react with boronic acids.[2] wide range of azoles with arylboronic acids.
As a variety of metal-mediated biaryl formations through Our initial exploration focused on the monometallic palla-
aromatic C H activation have been popularized, the dium(II)-catalyzed C H arylation of various azoles with ar-
Suzuki–Miyaura-type reactions, in which aryl halides or ylboronic acids in the presence of inorganic oxidants (e.g.,
pseudohalides are replaced by (hetero)arenes, have recently CuACHTUNGRE(OAc)2, Ag2CO3, and Ag2O), organic oxidants (e.g.,
attracted attention. This type of cross-coupling is not only DDQ (2,3-dichloro-5,6-dicyanobenzoquinone), and BQ
an efficient and complementary process to form biaryls, but (benzoquinone)), and/or dioxygen (O2). Whereas p-electron
also is in connection with sustainable chemistry. Whereas excessive five-membered heterocycles (i.e., thiophenes,
the Suzuki–Miyaura-type direct C H arylation of arenes furans, and pyrroles) smoothly coupled with arylboronic
(which generally require a directing group) has been devel- acids through an electrophilic mechanism, the azoles investi-
oped greatly,[3] the coupling of heteroarenes with arylboron- gated herein gave only trace amount to low yields of the de-
ic acids still remains elusive. In comparison with arenes, het- sired products.[4, 5] Although both types of heteroarenes are
eroarenes themselves are susceptible to oxidative homocou- electron-rich, the C2 sites of azoles are relatively electron-
pling and decomposition as well as self-coupling of arylbor- deficient. We believe that the distinctly differential p-elec-
onic acids in the presence of a PdII species. As far as we tronic characteristics may induce the clear distinctness of re-
know, only a few successful examples relative to heteroar- activity. Owing to the relatively acidic C2 sites, azoles are
enes have been described so far. Shi et al. described a PdII- unsusceptible to electrophilic C H substitution (SEAr) of
catalyzed cross-coupling of electron-rich heteroarenes (i.e., PdII under mild conditions. Considering that CuI salts have
pyrrole, furan, and thiophene derivatives) with arylboronic been used as catalysts or activators in direct C H arylations
acids under mild conditions.[4] Studer et al. reported the first of azoles,[7] we envisioned whether the additional introduc-
direct C H arylation of indoles with arylboronic acids and tion of a catalyic amount of CuI salt could assist the C2 H
the 2,2,6,6-tetramethylpiperidine N-oxyl radical (TEMPO) bond activation to generate an azole–copper species, which
as an external mild oxidant at room temperature.[5] Al- could undertake a transmetalation to arylpalladium(II) in-
though the aryl–azole structural motifs are ubiquitous in termediate to enable a catalytic cycle. Herein, we disclose
biologically important natural products, synthetic pharma- an efficient palladium/copper co-catalytic system for the
ceuticals, and materials,[6] it is unknown that the direct C H direct C H arylation of a variety of azoles with arylboronic
acids to extend current synthetic methodologies.
Xanthines (e.g., caffeine, theophylline, and theobromine)
[a] B. Liu, X. Qin, K. Li, X. Li, Q. Guo, Prof. Dr. J. Lan, Prof. Dr. J. You
Key Laboratory of Green Chemistry and are important biologically active alkaloids with imidazole
Technology of Ministry of Education skeletons. 8-(Hetero)aryl-substituted xanthines are highly
College of Chemistry, and State Key Laboratory of Biotherapy potent and selective antagonists at human A2B adenosine re-
West China Medical School, Sichuan University ceptors.[8] Following our continuing interest in the direct C
29 Wangjiang Road, Chengdu 610064 (P.R. China)
Fax: (+ 86) 28-85412203
arylation of xanthines, we initially focused on the heterocou-
E-mail: [email protected] pling of caffeine 1 with phenylboronic acid 2 a (Scheme 1).
Supporting information for this article is available on the WWW In this model reaction we screened several parameters (e.g.,
under http://dx.doi.org/10.1002/chem.201001338. oxidant, base, solvent, and additive) shown in Table 1.
11836 2010 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim Chem. Eur. J. 2010, 16, 11836 – 11839
COMMUNICATION
With optimized conditions now in hand, we explored the
scope of this methodology with respect to arylboronic acid
structure as summarized in Table 2. It was gratifying to find
Scheme 1. Direct C H arylation of caffeine with phenylboronic acid. Table 2. Catalytic C arylation of caffeine with various arylboronic acids.[a]
Chem. Eur. J. 2010, 16, 11836 – 11839 2010 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim www.chemeurj.org 11837
J. You et al.
Table 3. Catalytic C arylation of (hetero)arenes with boronic acids.[a] ylboronic acids (Scheme 3).[14] Interestingly, this bimetallic
catalytic method was capable of allowing the direct synthesis
of 3-arylated indolizines from indolizine through the C H
arylation with arylboronic acids in one step.
copper species IM2, and subsequent transmetalation with ar- Experimental Section
ylpalladium species IM1 to form the key heterocoupling in-
termediate IM3, followed by reductive elimination to pro- A flame-dried Schlenk test tube with a magnetic stirrer bar was charged
with PdACHTUNGRE(OAc)2 (5.6 mg, 0.025 mmol), N-heteroarene (0.5 mmol), arylbor-
duce the desired product. Pd0 could be reoxidized by Cu-
onic acid (1.0 mmol), CuACHTUNGRE(OAc)2 (0.5 mmol), CuCl (0.05 mmol), BQ
ACHTUNGRE(OAc)2 to complete the catalytic cycle; 2) Given that other (0.25 mmol), KF (0.5 mmol), and NMP (1.0 mL) under N2. A rubber
oxidants including inorganic oxidants, organic oxidants, and/ septum was replaced with a glass stopper, and the system was then evacu-
or dioxygen mentioned above were completely incapable of ated twice and back-filled with N2. The reaction mixture was stirred for
fulfilling the catalytic cycle, we rationalized that an (even 5 min at room temperature, and then heated at the indicated temperature
for 30 h. The reaction mixture was then cooled to ambient temperature,
catalytic) amount of copper(I) formed from CuACHTUNGRE(OAc)2 could
diluted with CH2Cl2 (20 mL), filtered through a celite pad, and washed
promote the formation of the azole–copper species to carry with CH2Cl2 (10–20 mL). The combined organic extracts were concen-
out the transmetalation in the absence of CuCl trated and the resulting residue was purified by column chromatography
(Scheme 2).[7, 11, 12] on silica gel to provide the desired product.
Acknowledgements
This work was supported by grants from the National NSF of China (Nos
20972102, 20872101 and 20772086) and PCSIRT (No IRT0846). We
thank the Centre of Testing & Analysis, Sichuan University for NMR
measurements.
11838 www.chemeurj.org 2010 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim Chem. Eur. J. 2010, 16, 11836 – 11839
COMMUNICATION
Pd/Cu Bimetallic Catalytic System
[2] a) N. Miyaura, A. Suzuki, Chem. Rev. 1995, 95, 2457; b) A. F. Littke, Faul, J. Am. Chem. Soc. 2010, 132, 3674. For CuI salts as activator,
G. C. Fu, Angew. Chem. 2002, 114, 4350; Angew. Chem. Int. Ed. see: d) A. Mori, A. Sekiguchi, K. Masui, T. Shimada, M. Horie, K.
2002, 41, 4176; c) H. Doucet, Eur. J. Org. Chem. 2008, 2013. Osakada, M. Kawamoto, T. Ikeda, J. Am. Chem. Soc. 2003, 125,
[3] a) F. Kakiuchi, S. Kan, K. Igi, N. Chatani, S. Murai, J. Am. Chem. 1700; e) L.-C. Campeau, D. R. Stuart, J.-P. Leclerc, M. Bertrand-La-
Soc. 2003, 125, 1698; b) F. Kakiuchi, Y. Matsuura, S. Kan, N. Chata- perle, E. Villemure, H.-Y. Sun, S. Lasserre, N. Guimond, M. Leca-
ni, J. Am. Chem. Soc. 2005, 127, 5936; c) R. Giri, N. Maugel, J.-J. Li, vallier, K. Fagnou, J. Am. Chem. Soc. 2009, 131, 3291. Also see ref-
D.-H. Wang, S. P. Breazzano, L. B. Saunders, J.-Q. Yu, J. Am. Chem. erences [6c], [6d], and [6h].
Soc. 2007, 129, 3510; d) Z. Shi, B. Li, X. Wan, J. Cheng, Z. Fang, B. [8] a) J. W. Daly, W. Padgett, M. T. Shamim, P. Butts-Lamb, J. Waters, J.
Cao, C. Qin, Y. Wang, Angew. Chem. 2007, 119, 5650; Angew. Med. Chem. 1985, 28, 487; b) Y.-C. Kim, X.-D. Ji, N. Melman, J.
Chem. Int. Ed. 2007, 46, 5554; e) D.-H. Wang, T.-S. Mei, J.-Q. Yu, J. Linden, K. A. Jacobson, J. Med. Chem. 2000, 43, 1165; c) A. M. Hay-
Am. Chem. Soc. 2008, 130, 17676; f) B.-F. Shi, N. Maugel, Y.-H. allah, J. Sandoval-Ramez, U. Reith, U. Schobert, B. Preiss, B. Schu-
Zhang, J.-Q. Yu, Angew. Chem. 2008, 120, 4960; Angew. Chem. Int. macher, J. W. Daly, C. E. Mller, J. Med. Chem. 2002, 45, 1500; d) L.
Ed. 2008, 47, 4882; g) T. Vogler, A. Studer, Org. Lett. 2008, 10, 129; Yan, C. E. Mller, J. Med. Chem. 2004, 47, 1031; e) P. G. Baraldi,
h) I. Ban, T. Sudo, T. Taniguchi, K. Itami, Org. Lett. 2008, 10, 3607; M. A. Tabrizi, D. Preti, A. Bovero, R. Romagnoli, F. Fruttarolo,
i) J. Wen, J. Zhang, S.-Y. Chen, J. Li, X.-Q. Yu, Angew. Chem. 2008, N. A. Zaid, A. R. Moorman, K. Varani, S. Gessi, S. Merighi, P. A.
120, 9029; Angew. Chem. Int. Ed. 2008, 47, 8897; j) H. Zhou, W.-J. Borea, J. Med. Chem. 2004, 47, 1434; f) R. V. Kalla, E. Elzein, T.
Chung, Y.-H. Xu, T.-P. Loh, Chem. Commun. 2009, 3472; k) Y. Wei, Perry, X. Li, V. Palle, V. Varkhedkar, A. Gimbel, T. Maa, D. Zeng,
J. Kan, M. Wang, W. Su, M. Hong, Org. Lett. 2009, 11, 3346; l) C.-L. J. Zablocki, J. Med. Chem. 2006, 49, 3682.
Sun, N. Liu, B.-J. Li, D.-G. Yu, Y. Wang, Z.-J. Shi, Org. Lett. 2010, [9] a) S. Sivakova, S. J. Rowan, Chem. Soc. Rev. 2005, 34, 9; b) F. J. M.
12, 184; m) T. Nishikata, A. R. Abela, S. Huang, B. H. Lipshutz, J. Hoeben, P. Jonkheijm, E. W. Meijer, A. P. H. J. Schenning, Chem.
Am. Chem. Soc. 2010, 132, 4978. Rev. 2005, 105, 1491; c) J. T. Davis, G. P. Spada, Chem. Soc. Rev.
[4] S.-D. Yang, C.-L. Sun, Z. Fang, B.-J. Li, Y.-Z. Li, Z.-J. Shi, Angew. 2007, 36, 296; d) J. L. Sessler, C. M. Lawrence, J. Jayawickramarajah,
Chem. 2008, 120, 1495; Angew. Chem. Int. Ed. 2008, 47, 1473. Chem. Soc. Rev. 2007, 36, 314; e) R. S. Butler, P. Cohn, P. Tenzel,
[5] S. Kirchberg, R. Frçhlich, A. Studer, Angew. Chem. 2009, 121, 4299; K. A. Abboud, R. K. Castellano, J. Am. Chem. Soc. 2009, 131, 623.
Angew. Chem. Int. Ed. 2009, 48, 4235. [10] a) J. Liu, M. J. Robins, Org. Lett. 2005, 7, 1149; b) I. Čerňa, R. Pohl,
[6] For selected examples of direct arylation of azoles at C2 by using B. Klepetřov, M. Hocek, Org. Lett. 2006, 8, 5389; c) J. Pschierer,
halides, see: a) H. A. Chiong, O. Daugulis, Org. Lett. 2007, 9, 1449; H. Plenio, Org. Lett. 2009, 11, 2551; d) T. E. Storr, C. G. Baumann,
b) G. L. Turner, J. A. Morris, M. F. Greaney, Angew. Chem. 2007, R. J. Thatcher, S. D. Ornellas, A. C. Whitwood, I. J. S. Fairlamb, J.
119, 8142; Angew. Chem. Int. Ed. 2007, 46, 7996; c) H.-Q. Do, O. Org. Chem. 2009, 74, 5810; e) D. Kim, H. Jun, H. Lee, S.-S. Hong, S.
Daugulis, J. Am. Chem. Soc. 2007, 129, 12404; d) L.-C. Campeau, M. Hong, Org. Lett. 2010, 12, 1212; f) I. Čerňa, R. Pohl, B. Klepetřov,
Bertrand-Laperle, J.-P. Leclerc, E. Villemure, S. Gorelsky, K. M. Hocek, J. Org. Chem. 2010, 75, 2302.
Fagnou, J. Am. Chem. Soc. 2008, 130, 3276; e) F. Besselivre, F. Ma- [11] P. Xi, F. Yang, S. Qin, D. Zhao, J. Lan, G. Gao, C. Hu, J. You, J. Am.
huteau-Betzer, D. S. Grierson, S. Piguel, J. Org. Chem. 2008, 73, Chem. Soc. 2010, 132, 1822.
3278; f) E. F. Flegeau, M. E. Popkin, M. F. Greaney, Org. Lett. 2008, [12] B. Ligault, D. Lapointe, L. Caron, A. Vlassova, K. Fagnou, J. Org.
10, 2717; g) T. Martin, C. Verrier, C. Hoarau, F. Marsais, Org. Lett. Chem. 2009, 74, 1826.
2008, 10, 2909; h) H.-Q. Do, R. M. K. Khan, O. Daugulis, J. Am. [13] a) J. P. Michael, Nat. Prod. Rep. 2007, 24, 191; b) J. P. Michael, Nat.
Chem. Soc. 2008, 130, 15185; i) J. Canivet, J. Yamaguchi, I. Ban, K. Prod. Rep. 2008, 25, 139; c) R. C. Oslund, N. Cermark, M. H. Gelb,
Itami, Org. Lett. 2009, 11, 1733. J. Med. Chem. 2008, 51, 4708; d) E. M. Beck, R. Hatley, M. J.
[7] For selected examples of CuI salts used as catalyst in direct C aryla- Gaunt, Angew. Chem. 2008, 120, 3046; Angew. Chem. Int. Ed. 2008,
tion of aromatic heterocycles, see: a) L. Ackermann, H. K. Potuku- 47, 3004.
chi, D. Landsberg, R. Vicente, Org. Lett. 2008, 10, 3081; b) D. Zhao, [14] J.-B. Xia, S.-L. You, Org. Lett. 2009, 11, 1187.
W. Wang, F. Yang, J. Lan, L. Yang, G. Gao, J. You, Angew. Chem.
2009, 121, 3346; Angew. Chem. Int. Ed. 2009, 48, 3296; c) J. Huang, Received: May 17, 2010
J. Chan, Y. Chen, C. J. Borths, K. D. Baucom, R. D. Larsen, M. M. Published online: September 6, 2010
Chem. Eur. J. 2010, 16, 11836 – 11839 2010 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim www.chemeurj.org 11839